ALNOV:EPA
Novacyt SA
0,45 €
0,00%
(0,00) 1 d.
16. 11., 17:35:17 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALNOV…
Otvoriť
0,45 €
Vysoká
0,45 €
Nízka
0,44 €
Trh. kap.
32,23 mil.
Priem. obj.
160,94 tis.
Objem
464,46 tis.
Max. za 52 týž.
1,04 €
Min. za 52 týž.
0,29 €
Výnosy na akciu
-0,38 €
Akcie v obehu
72,59 mil.
Počet zamestnancov
228
Otvoriť
0,45 €
Vysoká
0,45 €
Nízka
0,44 €
Trh. kap.
32,23 mil.
Priem. obj.
160,94 tis.
Objem
464,46 tis.
Max. za 52 týž.
1,04 €
Min. za 52 týž.
0,29 €
Výnosy na akciu
-0,38 €
Akcie v obehu
72,59 mil.
Počet zamestnancov
228
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
marketscreener.com
·
pred 5 hodinami
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
BigGo Finance
·
pred 13 hodinami
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
ChartMill
·
pred 9 hodinami
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
pred 2 hodinami
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Informácie o subjekte Novacyt SA
Generálny riaditeľDavid Allmond
Zamestnanci228
Dátum založenia3. 7. 2006
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-
Webnovacyt.com